TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,101,000 | -18.5% | 240,550 | -70.9% | 0.00% | -20.0% |
| Q1 2022 | $22,201,000 | -28.0% | 826,842 | +27.9% | 0.01% | -16.7% |
| Q4 2021 | $30,825,000 | +82.9% | 646,226 | +154.8% | 0.01% | +100.0% |
| Q3 2021 | $16,850,000 | +1330.4% | 253,648 | +1580.7% | 0.00% | – |
| Q2 2021 | $1,178,000 | -88.5% | 15,092 | -86.0% | 0.00% | -100.0% |
| Q1 2021 | $10,233,000 | +281.1% | 108,186 | +391.0% | 0.00% | – |
| Q4 2020 | $2,685,000 | -71.8% | 22,034 | -79.8% | 0.00% | -100.0% |
| Q3 2020 | $9,525,000 | +187.8% | 109,022 | +112.8% | 0.00% | +200.0% |
| Q2 2020 | $3,310,000 | +522.2% | 51,241 | +330.1% | 0.00% | – |
| Q1 2020 | $532,000 | -71.3% | 11,913 | -73.8% | 0.00% | -100.0% |
| Q2 2019 | $1,854,000 | – | 45,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |